Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. L. Palomba"'
Autor:
T. A. Eyre, M. L. Wang, N. N. Shah, A. J. Alencar, J. N. Gerson, M. R. Patel, B. Fakhri, E. Vandenberghe, W. Jurczak, X. N. Tan, K. L. Lewis, T. Fenske, Y. Wang, C. C. Coombs, I. Flinn, D. Lewis, S. Le Gouill, M. Gandhi, C. Chay, M. L. Palomba, J. A. Woyach, J. M. Pagel, N. Lamanna, J. P. Sharman, D. J. Andorsky, J. B. Cohen, M. A. Barve, P. Ghia, M. Yin, P. L. Zinzani, C. Ujjani, Y. Koh, K. Izutsu, E. Lech-Maranda, J. Kherani, C. Tam, S. Sundaram, B. Nair, D. E. Tsai, M. Balbas, A. R. Mato, C. Y. Cheah
Publikováno v:
HemaSphere, Vol 6, Pp 991-992 (2022)
Externí odkaz:
https://doaj.org/article/30ba6df675294f72a53a69707358acb9
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
The MYD88 L265P somatic variant (MYD88) has a high prevalence in Waldenstrom’s Macroglobulinemia (WM), a form of lymphoplasmacytic lymphoma (LPL) associated with monoclonal IgM. Although the role of MYD88 in WM was initially reported in 2012, it wa
Externí odkaz:
https://doaj.org/article/684de7cbd71d48f8b29a9d329cbd7d16
Autor:
S. P. Iyer, R. A. Sica, P. J. Ho, B. Hu, J. Zain, A. Prica, W.-K. Weng, Y. H. Kim, M. S. Khodadoust, M. L Palomba, F. M. Foss, K. Tipton, E. L. Cullingford, Q. He, A. Sharma, S. M. Horwitz
Publikováno v:
HemaSphere. 6:163-164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df588354e2dccfc931fe6de6a8740f68
https://doi.org/10.1097/01.hs9.0000843940.96598.e2
https://doi.org/10.1097/01.hs9.0000843940.96598.e2
Autor:
Syed S Mahmood, Peter A Riedell, Stephanie Feldman, Jennifer Liu, Gina George, Stephen A Sansoterra, Elena Mead, Thomas Althaus, Lauren Balkan, Tarek A Barbar, Katherine Lee Chuy, Bhisham Harchandani, Miguel Perales, Mark Geyer, Jae Park, M L Palomba, Roni Shouval, Ana A ALARCON TOMAS, Eric Yang, Daria L Gaut, Raza Alvi, Michael Rothberg, Jonathan W Weinsaft, Richard B Devereux, Evelyn M Horn, John P Leonard, Koen van Besien, Tomas G Neilan, Richard Steingart
Publikováno v:
Circulation. 144
Introduction: Chimeric antigen receptor T cell (CAR-T) therapy harnesses a patient’s own immune system to target cancer. Cardiotoxicity occurs in up to 25% of patients treated with CAR-T. There are limited data characterizing the association betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06912e2b7d51200f7b00e8f2b33b7cda
https://doi.org/10.1161/circ.144.suppl_1.10135
https://doi.org/10.1161/circ.144.suppl_1.10135
Publikováno v:
Journal of Biological Chemistry. 269:16925-16932
Thrombomodulin (TM) is an essential cofactor for the physiologic activation of the anticoagulant protein C by thrombin. We have observed that the expression of TM mRNA in response to retinoic acid was markedly increased in human U937 monoblast-like c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::219bf5c4ad9b2148b3e1fd0f181350ea
https://doi.org/10.1016/s0021-9258(19)89478-4
https://doi.org/10.1016/s0021-9258(19)89478-4
Publikováno v:
Cancer research. 51(18)
A monoclonal antibody, designated 3.2.3, which recognizes a novel Mr 60,000 disulfide-linked lytic triggering structure present on rat large granular lymphocytes and natural killer (NK) cells was recently described (W. H. Chambers et al., J. Exp. Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28b1626a00406f216e763afecd778ca4
https://pubmed.ncbi.nlm.nih.gov/1893382
https://pubmed.ncbi.nlm.nih.gov/1893382